Scholarly Index
Thomas D. Penning
AbbVie (United States); 7,289 total citations; 82 total publications; best world rank #570
AbbVie (United States)
7,289Total citations
82Total publications
30H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| PARP inhibition in cancer therapy | Lifetime | 570 | US 259 | 93.97 |